文献速递肺外科

同侧异时性第二原发非小细胞肺癌的重复解剖性肺切除手术结果

Repeated anatomical pulmonary resection for metachronous ipsilateral second non-small cell lung cancer.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-07-16

该回顾性研究纳入104例(3.6%)因同侧异时性第二原发非小细胞肺癌行手术切除的患者,其中56例行重复解剖性切除。避免全肺切除的重复解剖性切除在技术上有挑战,但肿瘤学和手术结果与完成性全肺切除相比均可行。

要点

  • 避免完成性全肺切除的重复解剖性切除与完成性全肺切除的肿瘤学和手术结果相似。

核心结论

  • 重复解剖性肺切除对同侧异时性第二原发非小细胞肺癌显示出可接受的肿瘤学结果。
  • 避免完成性全肺切除的术式技术上具有挑战性,但肿瘤学和手术结果与完成性全肺切除相比均可行。

研究设计与样本

  • 回顾性研究,识别104例(3.6%)因同侧异时性第二原发非小细胞肺癌行手术切除的患者。
  • 重复解剖性切除定义为同侧原发肺癌主要肺切除术后因第二原发非小细胞肺癌行异时性解剖性手术。
  • 采用多变量模型分析手术并发症或其他临床病理因素,采用Cox比例风险模型评估总生存率。

临床怎么用

  • 对于经过适当选择的同侧异时性第二原发非小细胞肺癌患者,重复解剖性肺切除是可接受的肿瘤学策略。
  • 避免完成性全肺切除的重复解剖性切除在技术上有挑战,但可作为完成性全肺切除的可行替代方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We investigated the surgical outcomes of repeated pulmonary resection for metachronous ipsilateral second non-small cell lung cancer (NSCLC). METHODS: A retrospective review identified 104 (3.6%) patients who underwent surgical resection for ipsilateral metachronous second NSCLC. Repeated anatomical (reanatomical) resection was defined as a metachronous anatomical surgery for secondary NSCLC after ipsilateral primary major lung resection for NSCLC. Operative morbidity or other clinicopathologic factors were analyzed by a multivariable model. Overall survival (OS) was evaluated using Cox proportional hazard model. RESULTS: Seventy-seven (74%) patients were diagnosed as second primary cases. The 3-year OS after metachronous surgery for ipsilateral second NSCLC was 80.1%, and that of reanatomical resection was equivalent to the other procedures (reanatomical: 81.8%, others: 78.2%, P = .816), whereas reanatomical resection (n = 56) was a significant predictor of postoperative severe morbidity after ipsilateral second pulmonary resection (P = .036) that was found in 23 (41%) patients. When this procedure was classified into 2 groups, ie, completion pneumonectomy (CP; n = 26) and other reanatomical resection to avoid CP (non-CP; n = 32), non-CP was significant on the right side (P = .011), whereas intrapericardial procedure was employed frequently for both (CP: 85%, non-CP: 47%). In contrast, the oncologic outcome (3-year OS; 75.8% vs 87.1%, P = .881) and several surgical outcomes including morbidities were similar between CP and non-CP. CONCLUSIONS: Reanatomical pulmonary resection showed acceptable oncologic outcomes for metachronous ipsilateral second NSCLC. The non-CP procedure was technically challenging; however, both oncologic and surgical results were feasible compared with the CP. This procedure might be a promising novel strategy for properly selected ipsilateral second NSCLC.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Hattori A, Matsunaga T, Watanabe Y, et al. Repeated anatomical pulmonary resection for metachronous ipsilateral second non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020. PMID: 32859413. doi:10.1016/j.jtcvs.2020.06.124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。